1-19 of 19
Wei Du
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Differential Contributions of Pre- and Post-EMT Tumor Cells in Breast Cancer Metastasis

Ana Rita Lourenco, Yi Ban, Michael J. Crowley, Sharrell B. Lee, Divya Ramchandani, Wei Du, Olivier Elemento, Jason T. George, Mohit Kumar Jolly, Herbert Levine, Jianting Sheng, Stephen T. Wong, Nasser K. Altorki, Dingcheng Gao
Journal: Cancer Research
Series: Author Choice
Cancer Res (2020) 80 (2): 163–169.
DOI: https://doi.org/10.1158/0008-5472.CAN-19-1427
Published: 15 January 2020
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 5031: Regulatory T cell ablation accelerates early stage breast cancer progression

Wei Du, Leandro Martinez, Valentina Robila, Nicholas Clark, Michael Idowu, Paula Bos, Paula Bos
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 5031.
DOI: https://doi.org/10.1158/1538-7445.AM2019-5031
Published: 01 July 2019
View article
Journal Articles

Abstract 2175: Considerations in PDX mouse trial design and their relevance to human clinical trial outcomes

Jingjing Jiang, Ying Yan, Tingting Tan, Wei Du, Jiali Gu, Ling Qiu, Katherine Ye, Zhenyu Gu
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2175.
DOI: https://doi.org/10.1158/1538-7445.AM2018-2175
Published: 01 July 2018
View article
Journal Articles

Spi-B–Mediated Silencing of Claudin-2 Promotes Early Dissemination of Lung Cancer Cells from Primary Tumors

Wei Du, Xing Xu, Qing Niu, Xuexi Zhang, Yiliang Wei, Ziqiao Wang, Wei Zhang, Jun Yan, Yongxin Ru, Zheng Fu, Xiaobo Li, Yuan Jiang, Zhenyi Ma, Zhenfa Zhang, Zhi Yao, Zhe Liu
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (18): 4809–4822.
DOI: https://doi.org/10.1158/0008-5472.CAN-17-0020
Published: 14 September 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 3139: In vivo functional analyses of cancer gene variants for cancer driver identification and drug discovery

Jingjing Jiang, Tengfei Yu, Ying Yan, Wei Du, Tingting Tan, Xuqin Yang, Jiali Gu, Ling Qiu, Xin K. Ye, Zhenyu Gu
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3139.
DOI: https://doi.org/10.1158/1538-7445.AM2017-3139
Published: 01 July 2017
View article
Journal Articles

Abstract 755: Supporting precision cancer treatment decision with functional evaluation of cancer gene mutations and variants

Jingjing Jiang, Zhongguang Luo, Jia Wei, Guanglei Zhuang, Song Yi, Ying Yan, Tengfei Yu, Wei Du, Tingting Tan, Ling Qiu, Jiali Gu, Xin K. Ye, Jie Liu, Zhenyu Gu
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 755.
DOI: https://doi.org/10.1158/1538-7445.AM2017-755
Published: 01 July 2017
View article
Journal Articles

Abstract 560: A pan-inflammatory and precancerous disease analysis reveals key biological characteristics in chronic inflammatory diseases with high oncogenic risk

Chi Zhang, Fang Yao, Sha Cao, Tao Sheng, Sen Liang, Wei Du, Ying Xu
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 560.
DOI: https://doi.org/10.1158/1538-7445.AM2017-560
Published: 01 July 2017
View article
Journal Articles

Effective Combination Therapies for B-cell Lymphoma Predicted by a Virtual Disease Model

Wei Du, Rebecca Goldstein, Yanwen Jiang, Omar Aly, Leandro Cerchietti, Ari Melnick, Olivier Elemento
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (8): 1818–1830.
DOI: https://doi.org/10.1158/0008-5472.CAN-16-0476
Published: 13 April 2017
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 3982: Prediction and selection of cancer drug treatments using personalized tumor models or models with matching genomic profiles

Jingjing Jiang, Ying Yan, Zhongguang Luo, Jia He, Tengfei Yu, Wei Du, Xuqin Yang, Jiali Gu, Xin K. Ye, Guanglei Zhuang, Jie Liu, Zhenyu Gu
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3982.
DOI: https://doi.org/10.1158/1538-7445.AM2016-3982
Published: 15 July 2016
View article
Journal Articles

Abstract 395: Patient stratification and drug combination strategy based on drug response and genomic information from PDX clinical trials (PCTs)

Jingjing Jiang, Tengfei Yu, Ying Yan, Wei Du, Tingting Tan, Xuqin Yang, Jiali Gu, Xin K. Ye, Zhenyu Gu
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 395.
DOI: https://doi.org/10.1158/1538-7445.AM2016-395
Published: 15 July 2016
View article
Journal Articles

Abstract 1476: Effect of target therapies in liver cancer PDX tumor models: Response, resistance and predictive biomarkers

Tengfei Yu, Ying Yan, Wei Du, Liang Hua, Xuqin Yang, Tingting Tan, Jiali Gu, Jingjing Jiang, Xin K. Ye, Zhenyu Gu
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1476.
DOI: https://doi.org/10.1158/1538-7445.AM2015-1476
Published: 01 August 2015
View article
Journal Articles

Abstract 3222: Biomarker discovery through bioinformatic analysis of genomic profiles of PDX models with different responses to cancer therapies

Jingjing Jiang, Tengfei Yu, Ying Yan, Wei Du, Tingting Tan, Xuqin Yang, Jiali Gu, Liang Hua, Katherine Xin Ye, Zhenyu Gu
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3222.
DOI: https://doi.org/10.1158/1538-7445.AM2015-3222
Published: 01 August 2015
View article
Journal Articles

Abstract 1210: A patient derived xenograft tumor model platform for “mouse trials”

Ying Yan, Tengfei Yu, Wei Du, Guosheng Tong, Yuefei Yang, Tingting Tan, Xuqin Yang, Zhenhua Liu, Jiali Gu, Liang Hua, Wei Zhang, Xin K. Ye, Zhenyu Gu
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1210.
DOI: https://doi.org/10.1158/1538-7445.AM2014-1210
Published: 01 October 2014
View article
Journal Articles

Abstract 1212: Studying cancer drug resistance in patient derived xenograft tumor models

Tengfei Yu, Ying Yan, Wei Du, Yuefei Yang, Tingting Tan, Xuqin Yang, Jiali Gu, Liang Hua, Xin K. Ye, Zhenyu Gu
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1212.
DOI: https://doi.org/10.1158/1538-7445.AM2014-1212
Published: 01 October 2014
View article
Journal Articles

Abstract 4402: Synergistic cell death in nedd8 and hrb27c mutant cells under an rbf-negative background is dependent on EGFR/MAPK signaling

Robin Zhang, Tianyi Zhang, Zhentao Sheng, Wei Du
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4402.
DOI: https://doi.org/10.1158/1538-7445.AM2014-4402
Published: 01 October 2014
View article
Journal Articles

The human bone morphogenetic protein antagonist BARC is downregulated in renal cancers

Kimberly Blish, Mark Willingham, Wei Du, Charles Birse, Surekha Krishnan, Julie Brown, Wei Wang, Gregory Hawkins, A. Garvin, Ralph D'Agostino, Frank Torti, Suzy Torti
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3785.
Published: 01 May 2007
View article
Journal Articles

Geranylgeranylated RhoB Mediates Suppression of Human Tumor Cell Growth by Farnesyltransferase Inhibitors

Wei Du, George C. Prendergast
Journal: Cancer Research
Cancer Res (1999) 59 (21): 5492–5496.
Published: 01 November 1999
View article
Journal Articles

Activation of the PI3′K-AKT Pathway Masks the Proapoptotic Effects of Farnesyltransferase Inhibitors

Wei Du, Aixue Liu, George C. Prendergast
Journal: Cancer Research
Cancer Res (1999) 59 (17): 4208–4212.
Published: 01 September 1999
View article
Journal Articles

Elevation of α2(I) Collagen, a Suppressor of Ras Transformation, Is Required for Stable Phenotypic Reversion by Farnesyltransferase Inhibitors

Wei Du, Peter F. Lebowitz, George C. Prendergast
Journal: Cancer Research
Cancer Res (1999) 59 (9): 2059–2063.
Published: 01 May 1999
View article